Cargando…
Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
MYC is one of the most deregulated oncogenes on multiple levels in cancer. As a node transcription factor, MYC plays a diverse regulatory role in many cellular processes, including cell cycle and metabolism, both in physiological and pathological conditions. The relentless growth and proliferation o...
Autores principales: | Vízkeleti, Laura, Spisák, Sándor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341379/ https://www.ncbi.nlm.nih.gov/pubmed/37443779 http://dx.doi.org/10.3390/cells12131745 |
Ejemplares similares
-
Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
por: Lee, Haksoo, et al.
Publicado: (2022) -
MYC Deregulation in Primary Human Cancers
por: Kalkat, Manpreet, et al.
Publicado: (2017) -
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
por: Tjaden, Britta, et al.
Publicado: (2020) -
Polyploidy and Myc Proto-Oncogenes Promote Stress Adaptation via Epigenetic Plasticity and Gene Regulatory Network Rewiring
por: Anatskaya, Olga V., et al.
Publicado: (2022) -
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)